MATTHEW WALKER: Open Payments
NPI 1588186928 · QUINCY, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$836 in 47 payments from 12 companies in 2025. Trend: 2023 $58 · 2024 $432 · 2025 $836
Food & beverage: $836
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $152 |
| E.R. Squibb & Sons, L.L.C. | 5 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $82 |
| Neurocrine BioSciences, Inc. | 4 | $81 |
| ABBVIE INC. | 3 | $77 |
| Janssen Pharmaceuticals, Inc | 4 | $73 |
| Alkermes, Inc. | 4 | $65 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $47 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
Products named: REXULTI, COBENFY, CAPLYTA, INGREZZA, VRAYLAR, SPRAVATO, ARISTADA, Auvelity.
Industry payments across IL — which companies pay providers there.
